Article

Genomic Strategies in Transplantation "The Right Drug for the Right Patient".

2004-06-01

Abstract excerpt

Purpose of review: The purpose of this review is to summarize recent advances in the area of genetic polymorphisms in genes affecting immunosuppressive drug bioavailability with a specific emphasis on solid organ transplantation. Recent findings: Due to recent advances in molecular techniques, there has been an abundance of publications describing genetic variability in molecules relevant to pharmacogenetics. The...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fb91026e-758b-5879-8d56-9996b08e82cc
DOI: 10.2174/1570160043377600

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genomic Strategies in Transplantation "The Right Drug for the Right Patient".DOI 10.2174/1570160043377600Read

New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs.Semantic proximity Read

Pharmacogenetics in solid organ transplantation: current status and future directions.Semantic proximity Read

Role of Pharmacogenetics of Immunosuppressive Drugs in Organ TransplantationSemantic proximity Read

Pharmacogenetics in Solid Organ Transplantation: Genes Involved in Mechanism of Action and Pharmacokinetics of Immunosuppressive DrugsSemantic proximity Read

Trends in Precision Medicine and Pharmacogenetics as an Adjuvant in Establishing a Correct Immunosuppressive Therapy for Kidney Transplant: An Up-to-Date Historical OverviewSemantic proximity Read

Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapySemantic proximity Read

Pharmacogenetics in Kidney TransplantationSemantic proximity Read

Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives.Semantic proximity Read

Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks.Semantic proximity Read

Insights into pharmacogenomics and its impact upon immunosuppressive therapy.Semantic proximity Read

Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted PatientsSemantic proximity Read

Practicability of pharmacogenetics in transplantation medicine.Semantic proximity Read